Salvage chemotherapy With CPT-11 for recurrent meningioma

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Neuro-Oncology

• Publication date

  2006-04-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11060-005-9093-xPMID 16628476
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gamma knife radiosurgery of imaging-diagnosed intracranial meningioma.

  2003cited by this paper
• Stereotactic radiosurgery providing long-term tumor control of cavernous sinus meningiomas.

  2002cited by this paper
• Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma.

  2002cited by this paper
• Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide.

  2002cited by this paper
• Hydroxyurea Chemotherapy for Unresectable or Residual Meningioma

  2000cited by this paper
• Stereotactic radiosurgery for meningiomas.

  1999cited by this paper
• Risk of injury to cranial nerves after gamma knife radiosurgery for skull base meningiomas: experience in 88 patients.

  1999cited by this paper
• The natural history of asymptomatic meningiomas in Olmsted County, Minnesota

  1998cited by this paper
• MENINGIOMAS: THE DECISION NOT TO OPERATE.

  1997cited by this paper
• Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and in meningioma transplants by induction of the apoptotic pathway.

  1997cited by this paper
• Meningiomas

  1997cited by this paper
• The treatment of recurrent unresectable and malignant meningiomas with interferon alpha-2B.

  1997cited by this paper
• Epidemiology and etiology of intracranial meningiomas: A review

  1996cited by this paper
• Chemotherapy for meningiomas

  1996cited by this paper
• Adjuvant combined modality therapy for malignant meningiomas.

  1996cited by this paper
• Interferon-alfa-2b for meningioma.

  1995cited by this paper
• Contemporary management of meningiomas: radiation therapy as an adjuvant and radiosurgery as an alternative to surgical removal?

  1994cited by this paper
• Meningiomas: genetics, malignancy, and the role of radiation in induction and treatment. The Richard C. Schneider Lecture.

  1994cited by this paper
• Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990.

  1994cited by this paper
• Contemporary management of meningiomas: radiation therapy as an adjuvant and radiosurgery as an alternative to surgical removal?

  1994cited by this paper
• Mifepristone (RU 486) treatment of meningiomas.

  1992cited by this paper
• Stereotactic radiosurgery of meningiomas.

  1991cited by this paper
• Inhibition of the growth of cultured human meningioma cells by recombinant interferon-alpha.

  1991cited by this paper
• Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone.

  1991cited by this paper
• Growth rate of incidental meningiomas.

  1990cited by this paper
• Lack of efficacy of megestrol acetate in the treatment of unresectable meningioma

  1990cited by this paper
• Response criteria for phase II studies of supratentorial malignant glioma.

  1990cited by this paper
• Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysis.

  1986cited by this paper
• Meningioma: analysis of recurrence and progression following neurosurgical resection.

  1985cited by this paper

• Meningioma: Novel Diagnostic and Therapeutic Approaches

  2025cites this paper
• Benchmarking the Efficacy of Salvage Systemic Therapies for Recurrent Meningioma: A RANO Group Systematic Review and Meta-analysis to Guide Clinical Trial Design.

  2025cites this paper
• Malignant Meningiomas: From Diagnostics to Treatment

  2025cites this paper
• Chemotherapy in the structure of complex treatment of patients with recurrent intracranial meningiomas

  2024cites this paper
• The Impact of Molecular and Genetic Analysis on the Treatment of Patients with Atypical Meningiomas

  2024cites this paper
• Impact on natural history of atypical meningioma after changes in 2016 edition of the world health organization (WHO) classification of central nervous system tumors: a literature review

  2024cites this paper
• Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients

  2024cites this paper
• Noncoding RNA landscape and their emerging roles as biomarkers and therapeutic targets in meningioma

  2024cites this paper
• Ways to personalize the treatment of patients with relapse and continued growth of intracranial meningiomas

  2023cites this paper
• The Role of Pharmacotherapy in Treatment of Meningioma: A Systematic Review

  2023cites this paper
• Medical Management of Meningiomas.

  2023cites this paper
• The role of radiation therapy and systemic treatments in meningioma: The present and the future

  2023cites this paper
• Novel Advances in Treatment of Meningiomas: Prognostic and Therapeutic Implications

  2023cites this paper
• Advances in the systemic therapy for recurrent meningiomas and the challenges ahead

  2023cites this paper
• Novel Medical Therapies in Meningiomas.

  2023cites this paper
• Clinical Significance of Molecular Alterations and Systemic Therapy for Meningiomas: Where Do We Stand?

  2022cites this paper
• Diagnostic and Therapeutic Strategy in Anaplastic (Malignant) Meningioma, CNS WHO Grade 3

  2022cites this paper
• The role of bevacizumab for treatment-refractory intracranial meningiomas: a single institution’s experience and a systematic review of the literature

  2022cites this paper
• Intracranial meningiomas: clinical, intrascopic and pathomorphological causes of recurrence (literature review)

  2022cites this paper
• Management of Recurrent Meningiomas: State of the Art and Perspectives

  2022cites this paper
• Docetaxel Targets Aggressive Methylation Profiles and Serves as a Radiosensitizer in High-Risk Meningiomas.

  2022cites this paper
• Pharmacological Landscape of FDA-approved Anticancer Drugs Reveals Sensitivities to Ixabepilone, Romidepsin, Omacetaxine, and Carfilzomib in Aggressive Meningiomas.

  2022cites this paper
• Emerging systemic treatment options in meningioma

  2022cites this paper
• High Grade Meningiomas: Current Therapy Based on Tumor Biology

  2021cites this paper
• 10 Management of Benign Skull Base Tumors in Neuro-oncology: Systemic Cytotoxic and Targeted Therapies Systemic cytotoxic and targeted therapies Benign skull base tumors in neuro-oncology

  2021cites this paper
• 36 Meningiomas Meningiomas

  2021cites this paper
• Discovering the Molecular Landscape of Meningioma: The Struggle to Find New Therapeutic Targets

  2021cites this paper
• Meningioma: not always a benign tumor. A review of advances in the treatment of meningiomas

  2021cites this paper
• Apatinib in recurrent anaplastic meningioma: a retrospective case series and systematic literature review

  2020cites this paper
• The Role of Medical Therapy for Menigniomas

  2020cites this paper
• Meningiomas: Comprehensive Strategies for Management

  2020cites this paper
• Review of Atypical and Anaplastic Meningiomas: Classification, Molecular Biology, and Management

  2020cites this paper
• Molecular Mechanism and Approach in Progression of Meningioma

  2020cites this paper
• Key Word and Full-Text Search Genomic Characterization of Meningiomas

  2019cites this paper
• Bevacizumab in refractory higher-grade and atypical meningioma: the current state of affairs

  2019cites this paper
• Unbiased global proteomic profiling of patient-derived meningiomas of all grades to identify molecular signatures of differentially expressed proteins and phosphoproteins.

  2019cites this paper
• Orbital optic nerve sheath meningioma

  2018cites this paper
• Systemic therapy for relapsed/refractory meningioma: Is there potential for antiangiogenic agents?

  2018cites this paper
• An overview of meningiomas.

  2018cites this paper
• Multiplatform profiling of meningioma provides molecular insight and prioritization of drug targets for rational clinical trial design

  2018cites this paper
• Role of bevacizumab for treatment-refractory meningiomas: A systematic analysis and literature review

  2018cites this paper
• Benign Intracranial Tumors.

  2018cites this paper
• Medical management of meningioma in the era of precision medicine.

  2018cites this paper
• Letter: Role of Tyrosine Kinase Inhibitors in Recurrent Meningiomas: Controversies and Promises.

  2018cites this paper
• Emerging Medical Treatments for Meningioma in the Molecular Era

  2018cites this paper
• Atypical and Malignant Meningiomas

  2017cites this paper
• Somatostatin receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to 68Ga-DOTATATE/-TOC uptake.

  2016cites this paper
• Combined Hydroxyurea and Verapamil in the Clinical Treatment of Refractory Meningioma: Human and Orthotopic Xenograft Studies.

  2016cites this paper
• Key Word and Full-Text Search Drug Therapy for Recurrent Progressive , Atypical , and Malignant Meningiomas

  2016cites this paper
• Anaplastic meningioma: octreotide therapy for a case of recurrent and progressive intracranial disease.

  2016cites this paper
• Medical Management of Meningiomas: Current Status, Failed Treatments, and Promising Horizons.

  2016cites this paper
• Kinetics of tumor size and peritumoral brain edema before, during, and after systemic therapy in recurrent WHO grade II or III meningioma.

  2016cites this paper
• Advanced radiation therapies for meningioma

  2016cites this paper
• Drug Resistance in Malignant Meningiomas

  2016cites this paper
• Systemic therapy for recurrent meningioma

  2016cites this paper
• Key Word and Full-Text Search Drug Therapy for Recurrent Progressive , Atypical , and Malignant Meningiomas

  2016cites this paper
• In vitro testing to a panel of potential chemotherapeutics and current concepts of chemotherapy in benign meningiomas.

  2015cites this paper
• Primary extradural meningioma presenting as a neck mass: Case report and review of the literature

  2015cites this paper
• Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma.

  2015cites this paper
• Hydroxyurea with or without imatinib in the treatment of recurrent or progressive meningiomas: a randomized phase II trial by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)

  2015cites this paper
• Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review.

  2014cites this paper
• A phase II trial of PTK787/ZK 222584 in recurrent or progressive radiation and surgery refractory meningiomas

  2014cites this paper
• Factores pronósticos del meningioma del paciente geriátrico

  2014cites this paper
• Metastatic Meningioma Presenting as Cancer of Unknown Primary

  2013cites this paper
• Medical management of meningiomas.

  2013cites this paper
• High-grade meningiomas: new avenues for drug treatment?

  2013cites this paper
• Systemic Treatment of Recurrent Meningioma

  2013cites this paper
• Recent developments in chemotherapy for meningiomas: a review.

  2013cites this paper
• Stereotactic radiosurgery for WHO II and III meningiomas: analysis of long-term clinical and radiographic outcomes.

  2013cites this paper
• Bevacizumab Treatment for Meningiomas in NF2: A Retrospective Analysis of 15 Patients

  2013cites this paper
• Chemotherapy: what is its role in meningioma?

  2012cites this paper
• Drug therapy for recurrent, progressive, atypical, and malignant meningiomas

  2012cites this paper
• Tumors of the meninges.

  2012cites this paper
• Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series

  2012cites this paper
• The role of chemotherapy and targeted therapy in the treatment of intracranial meningioma

  2012cites this paper
• Temozolomide Combined with Radiotherapy in the Treatment of Recurrent Cranial Meningioma Previously Treated with Multiple Surgical Resections and Two Sessions of Radiosurgery: A Case Report and Literature Review

  2012cites this paper
• Genomic Characterization of Meningiomas

  2012cites this paper
• Hydroxyurea for recurrent surgery and radiation refractory meningioma: a retrospective case series

  2011cites this paper
• Medical treatment of recurrent meningiomas

  2011cites this paper
• Treatment recommendations for primary extradural meningiomas

  2011cites this paper
• Olfactory groove meningioma.

  2011cites this paper
• Phase II study of Gleevec® plus hydroxyurea (HU) in adults with progressive or recurrent meningioma

  2011cites this paper
• Adult intradural primary spinal cord tumors.

  2011cites this paper
• Phase II study of subcutaneous octreotide in adults with recurrent or progressive meningioma and meningeal hemangiopericytoma.

  2011cites this paper
• Management of Meningeal Neoplasms: Meningiomas and Hemangiopericytomas

  2011cites this paper
• Medical therapies for meningiomas

  2010cites this paper
• CHAPTER 56 – Chemotherapy and Experimental Medical Therapies for Meningiomas

  2010cites this paper
• Outcome and survival following primary and repeat surgery for World Health Organization Grade III meningiomas.

  2010cites this paper
• Meningiomas

  2010cites this paper
• Transjugular extension of meningioma into the mediastinum—a case report

  2009cites this paper
• Chemotherapy, hormonal therapy, and immunotherapy for recurrent meningiomas

  2009cites this paper
• Advances in meningioma therapy

  2009influential citation
• Primary optic nerve tumours

  2009cites this paper
• Nonsurgical treatment options in the management of intracranial meningiomas.

  2009cites this paper
• Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08).

  2009cites this paper
• Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma

  2009cites this paper
• Meningiomas

  2008cites this paper
• Interferon‐α for recurrent World Health Organization grade 1 intracranial meningiomas

  2008cites this paper
• Malignant Meningiomas: Management and Outcome

  2008cites this paper
• Intracranial meningiomas : an overview of diagnosis and treatment

  2007cites this paper